Release Agreements in the Biotechnology Industry
132 Contracts & Agreements
- 2seventy bio, Inc. (1 contract)
- ABEONA THERAPEUTICS INC. (1)
- ACHIEVE LIFE SCIENCES, INC. (1)
- Adhera Therapeutics, Inc. (2)
- ADMA BIOLOGICS, INC. (1)
- Advaxis, Inc. (1)
- Adverum Biotechnologies, Inc. (1)
- Akebia Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (3)
- Alliqua BioMedical, Inc. (2)
- Altimmune, Inc. (3)
- AMARIN CORP PLC (1)
- Amgen Inc. (1)
- Arbutus Biopharma Corp (1)
- ARCA biopharma, Inc. (1)
- Arsanis, Inc. (1)
- Avidity Biosciences, Inc. (2)
- Axovant Sciences Ltd. (1)
- BAKKEN RESOURCES INC (1)
- Biogen Inc. (1)
- Blueprint Medicines Corp (1)
- CALADRIUS BIOSCIENCES, INC. (1)
- Celsion CORP (1)
- Chanticleer Holdings, Inc. (1)
- CHIMERIX INC (3)
- CLEVELAND BIOLABS INC (1)
- Conatus Pharmaceuticals Inc. (5)
- CTI BIOPHARMA CORP (1)
- CURIS INC (1)
- CYTORI THERAPEUTICS, INC. (2)
- DYADIC INTERNATIONAL INC (1)
- Eiger BioPharmaceuticals, Inc. (1)
- ENZON PHARMACEUTICALS, INC. (2)
- Erasca, Inc. (1)
- EXACT SCIENCES CORP (4)
- Exelixis (2)
- Finch Therapeutics Group, Inc. (1)
- FIVE PRIME THERAPEUTICS INC (1)
- Gemphire Therapeutics Inc. (1)
- GENEREX BIOTECHNOLOGY CORP (1)
- GENOCEA BIOSCIENCES, INC. (1)
- GLYCOMIMETICS INC (1)
- Greater Cannabis Company, Inc. (1)
- IMMUNE PHARMACEUTICALS INC (2)
- Immune Therapeutics, Inc. (1)
- INFINITY PHARMACEUTICALS, INC. (1)
- INSMED Inc (1)
- Isoray, Inc. (1)
- KalVista Pharmaceuticals, Inc. (3)
- LEXICON PHARMACEUTICALS, INC. (1)
- Ligand Pharmaceuticals Incorporated (1)
- Locust Walk Acquisition Corp. (3)
- MANNKIND CORP (8)
- MARIZYME INC (1)
- Molecular Templates, Inc. (4)
- Momenta Pharmaceuticals, Inc. (1)
- NAVIDEA BIOPHARMACEUTICALS, INC. (1)
- NEUROBIOLOGICAL TECHNOLOGIES INC (1)
- NOVAVAX INC (1)
- ORGANOVO HOLDINGS, INC. (1)
- Orgenesis Inc. (1)
- PharmaCyte Biotech, Inc. (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- Protagenic Therapeutics, Inc. (2)
- PROTEON THERAPEUTICS INC (2)
- PROTEOSTASIS THERAPEUTICS, INC. (1)
- Prothena Corp plc (2)
- Radius Health, Inc. (4)
- Regulus Therapeutics Inc. (1)
- RITTER PHARMACEUTICALS INC (1)
- Sarepta Therapeutics, Inc. (2)
- Sesen Bio, Inc. (1)
- Sorrento Therapeutics, Inc. (1)
- SPHERIX INC (1)
- SUNESIS PHARMACEUTICALS INC (2)
- Tonix Pharmaceuticals Holding Corp. (1)
- Trovagene, Inc. (1)
- TYME TECHNOLOGIES, INC. (4)
- Unity Biotechnology, Inc. (1)
- VBI Vaccines Inc (3)
- VITRO DIAGNOSTICS INC (1)
- Zentalis Pharmaceuticals, LLC (4)
- General Release of Claims, dated as of February 13, 2024, by and between eFFECTOR and Mayank Gandhi (Locust Walk Acquisition Corp., Filed With SEC on March 26, 2024)
- Release and Equity Agreement, by and between 2seventy bio, Inc. and Philip Gregory (2seventy bio, Inc., Filed With SEC on March 18, 2024)
- Mutual Release (VITRO DIAGNOSTICS INC, Filed With SEC on January 23, 2024)
- Assignment, Assumption and Release Agreement, dated September 21, 2023, between Scilex Holding Company, Oramed Pharmaceuticals, Inc., Sorrento Therapeutics, Inc. and Scintilla... (Sorrento Therapeutics, Inc., Filed With SEC on September 26, 2023)
- Asset Purchase Agreement, dated as of June 23, 2023, by and among Upsher-Smith Laboratories, LLC, Tonix Medicines, Inc. and Tonix Pharmaceuticals Holding Corp. Press Release of... (Tonix Pharmaceuticals Holding Corp., Filed With SEC on June 26, 2023)
- Release Agreement, dated February 13, 2023, by and between the Company and Armand Girard (GLYCOMIMETICS INC, Filed With SEC on May 3, 2023)
- Release Agreement, dated September 23, 2022. between Zentalis Pharmaceuticals, Inc. and Dimitris Voliotis (Zentalis Pharmaceuticals, LLC, Filed With SEC on November 9, 2022)
- Release Agreement, dated October 12, 2022, by and between PharmaCyte Biotech, Inc. and Gerald W. Crabtree (PharmaCyte Biotech, Inc., Filed With SEC on October 14, 2022)
- Press Release dated September 15, 2022 (VBI Vaccines Inc, Filed With SEC on September 15, 2022)
- Second Amendment to Release Agreement, dated as of September 2, 2022, by and between Tyme Technologies, Inc. and Michael Demurjian (TYME TECHNOLOGIES, INC., Filed With SEC on September 6, 2022)
- General Release of Claims, effective as of July 22, 2022, by and between eFFECTOR and Alana McNulty (Locust Walk Acquisition Corp., Filed With SEC on August 9, 2022)
- General Release of Claims, effective as of April 8, 2022, by and between eFFECTOR and Premal Patel, M.D., Ph.D (Locust Walk Acquisition Corp., Filed With SEC on August 9, 2022)
- Amendment to Release Agreement, effective April 18, 2022, by and between Michael Demurjian and Tyme Technologies, Inc (TYME TECHNOLOGIES, INC., Filed With SEC on May 25, 2022)
- Release Agreement, effective March 24, 2022, by and between Steve Hoffman and Tyme Technologies, Inc (TYME TECHNOLOGIES, INC., Filed With SEC on May 25, 2022)
- Release Agreement, dated May 10, 2022, between Zentalis Pharmaceuticals, Inc. and Anthony Y. Sun, M.D (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 16, 2022)
- Release Agreement, dated November 4, 2021, by and between Finch Therapeutics Group, Inc. and Zain Kassam (Finch Therapeutics Group, Inc., Filed With SEC on March 31, 2022)
- Mutual Release of Claims Agreement by and between Marizyme, Inc. and Nicholas DeVito dated August 27, 2020 (MARIZYME INC, Filed With SEC on February 14, 2022)
- Press release titled UNITY Biotechnology Announces Exclusive License Agreement with Jocasta Neuroscience to Continue Development of -Klotho Program (Unity Biotechnology, Inc., Filed With SEC on December 20, 2021)
- General Release of Claims, dated August 30, 2021, by and between Avidity Biosciences, Inc. and Jae B. Kim, M.D (Avidity Biosciences, Inc., Filed With SEC on November 9, 2021)
- RELEASE AGREEMENT (Gemphire Therapeutics Inc., Filed With SEC on August 16, 2021)
- Press Release Dated August 10, 2021 (DYADIC INTERNATIONAL INC, Filed With SEC on August 11, 2021)
- Release Agreement, dated December 15, 2020, by and between Gary Yeung and the Registrant (Erasca, Inc., Filed With SEC on June 25, 2021)
- General Release of Claims, dated December 15, 2020, between the Company and Charles Morris (Radius Health, Inc., Filed With SEC on February 25, 2021)
- General Release of Claims, dated as of September 22, 2020, by and between the Company and Jose (Pepe) Carmona (Radius Health, Inc., Filed With SEC on November 5, 2020)
- Partial Release and Acknowledgement Agreement, dated as of July 23, 2020, by and between the Company and MidCap Financial Trust (Radius Health, Inc., Filed With SEC on November 5, 2020)
- Release Agreement by and between Zeno Management, Inc. and Robert Winkler, M.D (Zentalis Pharmaceuticals, LLC, Filed With SEC on July 27, 2020)
- Form of Release Agreement by Keith Murphy in favor of the Companys directors and officers (ORGANOVO HOLDINGS, INC., Filed With SEC on July 15, 2020)
- Release Agreement dated December 19, 2019, by and between P. Kent Hawryluk and the Registrant (Avidity Biosciences, Inc., Filed With SEC on May 22, 2020)
- Release Agreement, dated May (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
- Mutual Release and Non-Disparagement Agreement effective April 30, 2020 (Immune Therapeutics, Inc., Filed With SEC on May 5, 2020)
- Resignation Agreement and Release by and between X4 Pharmaceuticals, Inc. and E. Lynne Kelley, M.D., dated March 18, 2020 (Arsanis, Inc., Filed With SEC on March 20, 2020)
- Release Agreement, dated October 1, 2019, between Prothena Biosciences Inc and A. W. Homan (Prothena Corp plc, Filed With SEC on March 3, 2020)
- Amended and Restated Release, dated January 28, 2020, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC, and Lordship Ventures Histogen Holdings LLC (Conatus Pharmaceuticals Inc., Filed With SEC on February 7, 2020)
- General Release of Claims, dated October 1, 2019, by and between David T. Hagerty, M.D. and the Registrant (Conatus Pharmaceuticals Inc., Filed With SEC on November 5, 2019)
- General Release of Claims, dated July 1, 2019, by and between Daniel L. Ripley and the Registrant (Conatus Pharmaceuticals Inc., Filed With SEC on November 5, 2019)
- General Release of Claims, dated July 1, 2019, by and between Edward F. Smith, III, Ph.D. and the Registrant (Conatus Pharmaceuticals Inc., Filed With SEC on November 5, 2019)
- Press Release, dated August 26, 2019 (Sesen Bio, Inc., Filed With SEC on August 26, 2019)
- Release of Claims Agreement, by and between the Company and Dr. Tasker, dated June 17, 2019 (Altimmune, Inc., Filed With SEC on August 13, 2019)
- Agreement and Release, dated June 6, 2019, by and between the Registrant and Timothy W. Trost (CHIMERIX INC, Filed With SEC on August 8, 2019)
- Release Agreement, dated as of March 15, 2019, between Tyme Technologies, Inc. and Michael Demurjian (TYME TECHNOLOGIES, INC., Filed With SEC on June 12, 2019)
